Applied Radiation Oncology

10/23/2026

🩻 Case Study of the Week - Diagnosis Time!

EHE with R0 resection and multifocal pT2N0 (i+) right breast cancer (ER 90%, PR 95%, HER2 DISH negative)

🔗 See all the case details, more images, and the diagnosis: https://zurl.co/vPYyi

10/23/2026

What’s shaping the future of radiation oncology? Check out the latest RadOnc Student Scan!

Explore fresh perspectives on immunotherapy, adaptive radiation therapy, emerging technologies, career development, and workforce innovation—plus a fascinating look at radiation oncology beyond Earth and a unique clinical case.

Discover the latest insights, emerging trends, and professional perspectives influencing the field. Read the articles today ➡️ https://zurl.co/QaZRq

10/22/2026

ASTRO 2026: Bringing an Evolving Science into Practice

📰🔗 Read more: https://zurl.co/OJfUZ

Scientific Committee Chair Kenneth Rosenzweig, MD, reflects on the research shaping shorter treatment courses, more focused radiation therapy, and an expanding role for radiation oncology.

Scientific Committee Chair Kenneth Rosenzweig, MD, reflects on the research shaping shorter treatment courses, more focused radiation therapy, and an…

10/22/2026

Radiation Oncology Coding for Medical Students: All You Ever Wanted to Know but Were Afraid to Ask

🔗 Read more: https://zurl.co/kMCqW

"Medical billing and coding is one area of medicine that remains mysterious and misunderstood for many practitioners, especially those at the beginning of their careers..."

10/21/2026

Want to hear more from radiation oncologist Ann Raldow, MD, MPH, of the David Geffen School of Medicine at UCLA?

Check out the rest of the interview: https://zurl.co/ubv8L

10/21/2026

Actinium Pharmaceuticals Reports Positive Initial Results from ATNM-400 Phase 1 Study in mCRPC

📰🔗 https://zurl.co/9jeSy

Actinium Pharmaceuticals, Inc. recently presented initial clinical findings from its first-in-human Phase 1 study of ATNM-400, an investigational radiotherapeutic for metastatic castration-resistant prostate cancer (mCRPC).

10/21/2026

Case Study: Stage 1A NLPHL Complete Response to 4 Gy VLDRT

Full case details: https://zurl.co/pvczF

We present the case of an adult man with stage 1A NLPHL involving right cervical lymph nodes treated with very low-dose radiation therapy (VLDRT) consisting of 4 Gy in 2 fractions following shared decision-making.

10/20/2026

Study Finds Pre-Operative MRI May Improve Long-Term Outcomes for Younger Breast Cancer Patients

🔗 Read the article: https://zurl.co/9qi4E

Published in Radiology, the journal of the RSNA, the study shows that patients who receive MRI scans before surgery experience improved outcomes, particularly women under the age of 50 at diagnosis and treatment.

10/20/2026

🩻 Case Study of the Week

A 47-year-old woman initially presented with cancer in her right breast, detected during screening. A core biopsy was suspicious for intraductal carcinoma.

🔗 See all the case details, more images, and the diagnosis: https://zurl.co/FvLAZ

10/16/2026

World Spine Day | October 16

The spine presents unique challenges in radiation oncology, particularly when treating metastatic disease near the spinal cord and other critical structures.

In recognition of World Spine Day, we're highlighting an Applied Radiation Oncology article exploring stereotactic body radiation therapy (SBRT) for oligometastatic spine disease, including patient selection, treatment considerations, and the importance of multidisciplinary care.

🔗 Read the article: https://zurl.co/0mLSy